• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化鼻咽癌放疗时机:放疗计划安排对生存的影响

Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival.

作者信息

Li Ying, Weng Youliang, Huang Zongwei, Wu Lishui, Xu Siqi, Xie Yingjie, Li Haolan, Lai Jinghua, Hu Dan, Qiu Sufang

机构信息

Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fujian, China.

Fujian Medical University, Fujian, China.

出版信息

JCO Precis Oncol. 2025 Jan;9:e2400603. doi: 10.1200/PO-24-00603. Epub 2025 Jan 7.

DOI:10.1200/PO-24-00603
PMID:39772833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11723500/
Abstract

PURPOSE

Chronoradiobiology has emerged as a potential field of study with therapeutic implications for cancer treatment. We aimed to investigate the association between radiation chronotherapy and the efficacy and toxicity of patients with nasopharyngeal carcinoma (NPC).

PATIENTS AND METHODS

Patients with nonmetastatic NPC treated with intensity-modulated radiotherapy in Fujian Cancer Hospital between January 2017 and December 2019 were included. Propensity score matching (PSM) with 1:1:1 was used to account for selection bias. Cox regression analysis was performed to explore the impact of radiotherapy timing on patient survival. Sensitivity analysis was implemented to determine the size and directional stability.

RESULTS

One thousand forty patients met study inclusion criteria and 332 patients were included in a PSM cohort. In the unmatched cohort analysis, morning radiotherapy exhibited a significantly superior overall survival (OS) outcome (hazard ratio [HR], 0.60 [95% CI, 0.40 to 0.91], adjusted log-rank = .028) than the afternoon one. After PSM analysis, it was observed that individuals undergoing radiotherapy in the afternoon group (HR, 5.88 [95% CI, 2.55 to 13.58], adjusted log-rank = .004) and the night group (HR, 4.81 [95% CI, 1.91 to 12.11], adjusted log-rank = .018) displayed a tendency toward shorter OS compared with the morning group. No significant differences in acute treatment-related adverse effects were observed among the three groups. Morning radiotherapy demonstrated consistent robustness in the multivariable analysis, thereby establishing an association with higher OS. The directionality of the effect size was consistent across sensitivity analysis.

CONCLUSION

These results underscore the potential benefits of scheduling radiotherapy in the morning for NPC management, although prospective studies are needed to confirm these findings.

摘要

目的

时间放射生物学已成为一个具有癌症治疗潜在研究意义的领域。我们旨在研究放射时间疗法与鼻咽癌(NPC)患者疗效及毒性之间的关联。

患者与方法

纳入2017年1月至2019年12月在福建医科大学附属肿瘤医院接受调强放疗的非转移性NPC患者。采用1:1:1倾向评分匹配(PSM)以消除选择偏倚。进行Cox回归分析以探讨放疗时间对患者生存的影响。实施敏感性分析以确定效应大小和方向稳定性。

结果

1040例患者符合研究纳入标准,332例患者纳入PSM队列。在未匹配队列分析中,与下午放疗相比,上午放疗的总生存(OS)结局显著更优(风险比[HR],0.60[95%置信区间,0.40至0.91],校正对数秩 = 0.028)。PSM分析后,观察到下午组(HR,5.88[95%置信区间,2.55至13.58],校正对数秩 = 0.004)和夜间组(HR,4.81[95%置信区间,1.91至12.11],校正对数秩 = 0.018)放疗患者的OS较上午组有缩短趋势。三组间急性治疗相关不良反应无显著差异。上午放疗在多变量分析中显示出一致的稳健性,从而建立了与更高OS的关联。效应大小的方向性在敏感性分析中保持一致。

结论

这些结果强调了上午安排放疗用于NPC治疗的潜在益处,尽管需要前瞻性研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/0a1ed7b90398/po-9-e2400603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/a6e91d03ee1a/po-9-e2400603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/5dd81e2e3c73/po-9-e2400603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/0a1ed7b90398/po-9-e2400603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/a6e91d03ee1a/po-9-e2400603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/5dd81e2e3c73/po-9-e2400603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa7/11723500/0a1ed7b90398/po-9-e2400603-g003.jpg

相似文献

1
Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival.优化鼻咽癌放疗时机:放疗计划安排对生存的影响
JCO Precis Oncol. 2025 Jan;9:e2400603. doi: 10.1200/PO-24-00603. Epub 2025 Jan 7.
2
Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma.放疗节奏对鼻咽癌预后的影响。
Ann Med. 2024 Dec;56(1):2407061. doi: 10.1080/07853890.2024.2407061. Epub 2024 Sep 23.
3
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.接受调强质子治疗与调强放射治疗的非转移性鼻咽癌患者的毒性谱和生存结局。
JAMA Netw Open. 2021 Jun 1;4(6):e2113205. doi: 10.1001/jamanetworkopen.2021.13205.
4
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.调强放疗时代 70 岁及以上老年鼻咽癌患者的特征和生存结局。
Cancer Res Treat. 2019 Jan;51(1):34-42. doi: 10.4143/crt.2017.551. Epub 2018 Feb 6.
5
Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy: A propensity score-matched analysis.调强放疗(IMRT)与调强放疗+碳离子放疗治疗非转移性鼻咽癌患者的生存结局和毒性特征:倾向评分匹配分析。
Head Neck. 2024 Jul;46(7):1766-1776. doi: 10.1002/hed.27771. Epub 2024 Apr 9.
6
Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.调强放疗时代鼻咽癌放疗中断对生存的影响:基于大数据智能平台的分析。
Radiother Oncol. 2019 Mar;132:178-187. doi: 10.1016/j.radonc.2018.10.018. Epub 2018 Nov 14.
7
Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.一项关于使用螺旋断层放疗对鼻咽癌进行同步调强加速放疗的II期研究的倾向评分匹配分析。
BMC Cancer. 2017 Aug 29;17(1):582. doi: 10.1186/s12885-017-3581-1.
8
Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.时程-放疗对局部晚期鼻咽癌患者预后和治疗相关毒性的影响:一项多中心倾向评分匹配研究。
Chronobiol Int. 2024 Apr;41(4):587-597. doi: 10.1080/07420528.2024.2337887. Epub 2024 Apr 12.
9
10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.调强放疗与二维放疗治疗鼻咽癌患者的 10 年疗效比。
Oncologist. 2019 Jan;24(1):e38-e45. doi: 10.1634/theoncologist.2017-0577. Epub 2018 Aug 6.
10
The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study.调强放疗后鼻咽癌患者残留颈部淋巴结中推量剂量的预后价值:一项回顾性研究
BMC Cancer. 2025 Feb 7;25(1):222. doi: 10.1186/s12885-025-13665-4.

本文引用的文献

1
Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma.放疗节奏对鼻咽癌预后的影响。
Ann Med. 2024 Dec;56(1):2407061. doi: 10.1080/07853890.2024.2407061. Epub 2024 Sep 23.
2
Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis.免疫疗法输注时间影响头颈部癌症的生存:倾向评分匹配分析。
Oral Oncol. 2024 Apr;151:106761. doi: 10.1016/j.oraloncology.2024.106761. Epub 2024 Mar 20.
3
Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders.
鼻咽癌放疗中采用个性化策略:超越传统射野和边界的局限
Cancers (Basel). 2024 Jan 16;16(2):383. doi: 10.3390/cancers16020383.
4
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.鼻咽癌精准医学:过去、现在和未来展望的全面综述。
J Transl Med. 2023 Nov 6;21(1):786. doi: 10.1186/s12967-023-04673-8.
5
Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy.昼夜节律对药物反应的调节:走向性别特异性和个体化时间治疗。
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:89-114. doi: 10.1146/annurev-pharmtox-051920-095416. Epub 2023 Sep 18.
6
Scheduling radiotherapy for patients with nasopharyngeal carcinoma in the corresponding time window can reduce radiation-induced oral mucositis: A randomized, prospective study.在相应的时间窗口内为鼻咽癌患者安排放射治疗可以减少放射性口腔黏膜炎:一项随机、前瞻性研究。
Cancer Med. 2023 Aug;12(15):16032-16040. doi: 10.1002/cam4.6252. Epub 2023 Aug 3.
7
Prognostic model on overall survival in elderly nasopharyngeal carcinoma patients: a recursive partitioning analysis identifying pre-treatment risk stratification.老年鼻咽癌患者总生存预后模型:识别治疗前风险分层的递归分区分析。
Radiat Oncol. 2023 Jun 23;18(1):104. doi: 10.1186/s13014-023-02272-x.
8
Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity-modulated radiotherapy treatment of T4 nasopharyngeal carcinoma.在 T4 期鼻咽癌调强放疗中,优先考虑给予肿瘤足够剂量,而非保护正常组织。
Head Neck. 2023 May;45(5):1130-1140. doi: 10.1002/hed.27315. Epub 2023 Mar 1.
9
Knockdown of Annexin A2 Enhances Radiosensitivity by Increasing G2/M-Phase Arrest, Apoptosis and Activating the p38 MAPK-HSP27 Pathway in Nasopharyngeal Carcinoma.敲低膜联蛋白A2通过增加G2/M期阻滞、诱导凋亡以及激活鼻咽癌中的p38丝裂原活化蛋白激酶-HSP27信号通路来增强放射敏感性。
Front Oncol. 2022 Mar 17;12:769544. doi: 10.3389/fonc.2022.769544. eCollection 2022.
10
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.检查点抑制剂纳武单抗的时间依赖性疗效:转移性非小细胞肺癌患者的一项初步研究结果
Cancers (Basel). 2022 Feb 11;14(4):896. doi: 10.3390/cancers14040896.